<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38891876</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>23</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Recent Progress in Innate Immune Responses to Enterovirus A71 and Viral Evasion Strategies.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5688</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25115688</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) is a major pathogen causing hand, foot, and mouth disease (HFMD) in children worldwide. It can lead to severe gastrointestinal, pulmonary, and neurological complications. The innate immune system, which rapidly detects pathogens via pathogen-associated molecular patterns or pathogen-encoded effectors, serves as the first defensive line against EV-A71 infection. Concurrently, the virus has developed various sophisticated strategies to evade host antiviral responses and establish productive infection. Thus, the virus-host interactions and conflicts, as well as the ability to govern biological events at this first line of defense, contribute significantly to the pathogenesis and outcomes of EV-A71 infection. In this review, we update recent progress on host innate immune responses to EV-A71 infection. In addition, we discuss the underlying strategies employed by EV-A71 to escape host innate immune responses. A better understanding of the interplay between EV-A71 and host innate immunity may unravel potential antiviral targets, as well as strategies that can improve patient outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Jialong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, Chongqing University, Chongqing 400044, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Linxi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2051-1206</Identifier><AffiliationInfo><Affiliation>School of Medicine, Chongqing University, Chongqing 400044, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Medicine, Chongqing University, Chongqing 400044, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-9529-4683</Identifier><AffiliationInfo><Affiliation>School of Medicine, Chongqing University, Chongqing 400044, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0166-9027</Identifier><AffiliationInfo><Affiliation>School of Medicine, Chongqing University, Chongqing 400044, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Precision Medicine, Chongqing University, Chongqing 400044, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Medicine, Chongqing University, Chongqing 400044, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023YFC2307401</GrantID><Agency>National Key Research and Development Program of China</Agency><Country /></Grant><Grant><GrantID>82372238</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>82372549</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>CSTB2023NSCQ-MSX0482</GrantID><Agency>Chongqing Natural Science grant</Agency><Country /></Grant><Grant><GrantID>CSTC2019JCYJ-MSXMX0266</GrantID><Agency>Chongqing Natural Science grant</Agency><Country /></Grant><Grant><GrantID>cx2023050</GrantID><Agency>the Venture &amp; Innovation Support Program for Chongqing Overseas Returnees</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057131" MajorTopicYN="Y">Immune Evasion</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">evasion strategies</Keyword><Keyword MajorTopicYN="N">hand, foot, and mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">innate immune response</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38891876</ArticleId><ArticleId IdType="pmc">PMC11172324</ArticleId><ArticleId IdType="doi">10.3390/ijms25115688</ArticleId><ArticleId IdType="pii">ijms25115688</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt N.J., Lennette E.H., Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 1974;129:304–309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778–790. doi: 10.1016/s1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer T.K., Simmonds P., Harvala H. The importance of enterovirus surveillance in a post-polio world. Lancet Infect. Dis. 2022;22:e35–e40. doi: 10.1016/s1473-3099(20)30852-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(20)30852-5</ArticleId><ArticleId IdType="pubmed">34265258</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu P., Ji W., Li D., Li Z., Chen Y., Dai B., Han S., Chen S., Jin Y., Duan G. Current status of hand-foot-and-mouth disease. J. Biomed. Sci. 2023;30:15. doi: 10.1186/s12929-023-00908-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-023-00908-4</ArticleId><ArticleId IdType="pmc">PMC9951172</ArticleId><ArticleId IdType="pubmed">36829162</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Zhou Y., Lu H., Yang H., Feng Q., Dai Y., Chen L., Yu S., Yao X., Zhang H., et al. Characterization of severe hand, foot, and mouth disease in Shenzhen, China, 2009–2013. J. Med. Virol. 2015;87:1471–1479. doi: 10.1002/jmv.24200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24200</ArticleId><ArticleId IdType="pubmed">25951788</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W., Su Y., Jiang M., Liu J., Zhang Y.Y., Nong G.M. Clinical features for 89 deaths of hand, foot and mouth disease in Guangxi, China, 2014. Int. J. Infect. Dis. 2017;64:15–19. doi: 10.1016/j.ijid.2017.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2017.08.016</ArticleId><ArticleId IdType="pubmed">28882666</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Li J.J., Liu T., Wen G.Q., Xiang W. Clinical and neuroimaging features of enterovirus71 related acute flaccid paralysis in patients with hand-foot-mouth disease. Asian Pac. J. Trop. Med. 2013;6:68–72. doi: 10.1016/s1995-7645(12)60203-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1995-7645(12)60203-x</ArticleId><ArticleId IdType="pubmed">23317889</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidd S., Lopez A., Nix W.A., Anyalechi G., Itoh M., Yee E., Oberste M.S., Routh J. Vital Signs: Clinical Characteristics of Patients with Confirmed Acute Flaccid Myelitis, United States, 2018. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1031–1038. doi: 10.15585/mmwr.mm6931e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6931e3</ArticleId><ArticleId IdType="pmc">PMC7454900</ArticleId><ArticleId IdType="pubmed">32759919</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Thibaut H.J., Strating J., van Kuppeveld F.J.M. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 2018;16:368–381. doi: 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.L., Shih S.R., Tolbert B.S., Brewer G. Enterovirus A71 Vaccines. Vaccines. 2021;9:199. doi: 10.3390/vaccines9030199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9030199</ArticleId><ArticleId IdType="pmc">PMC7997495</ArticleId><ArticleId IdType="pubmed">33673595</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K.R., Ling P. Interplays between Enterovirus A71 and the innate immune system. J. Biomed. Sci. 2019;26:95. doi: 10.1186/s12929-019-0596-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0596-8</ArticleId><ArticleId IdType="pmc">PMC6886175</ArticleId><ArticleId IdType="pubmed">31787104</ArticleId></ArticleIdList></Reference><Reference><Citation>Remick B.C., Gaidt M.M., Vance R.E. Effector-Triggered Immunity. Annu. Rev. Immunol. 2023;41:453–481. doi: 10.1146/annurev-immunol-101721-031732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-101721-031732</ArticleId><ArticleId IdType="pubmed">36750319</ArticleId></ArticleIdList></Reference><Reference><Citation>Deibel R., Gross L.L., Collins D.N. Isolation of a new enterovirus (38506). Proceedings of the Society for Experimental Biology and Medicine. Soc. Exp. Biol. Med. 1975;148:203–207. doi: 10.3181/00379727-148-38506.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/00379727-148-38506</ArticleId><ArticleId IdType="pubmed">165523</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick J.L. Enterovirus type 71 infections: A varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev. Infect. Dis. 1984;6((Suppl. S2)):S387–S390. doi: 10.1093/clinids/6.supplement_2.s387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/6.supplement_2.s387</ArticleId><ArticleId IdType="pubmed">6330839</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindarov L.M., Chumakov M.P., Voroshilova M.K., Bojinov S., Vasilenko S.M., Iordanov I., Kirov I.D., Kamenov E., Leshchinskaya E.V., Mitov G., et al. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J. Hyg. Epidemiol. Microbiol. Immunol. 1979;23:284–295.</Citation><ArticleIdList><ArticleId IdType="pubmed">231067</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy G., Takátsy S., Kukán E., Mihály I., Dömök I. Virological diagnosis of enterovirus type 71 infections: Experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch. Virol. 1982;71:217–227. doi: 10.1007/bf01314873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf01314873</ArticleId><ArticleId IdType="pubmed">6285858</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sanden S., Koopmans M., Uslu G., van der Avoort H. Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008. J. Clin. Microbiol. 2009;47:2826–2833. doi: 10.1128/jcm.00507-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.00507-09</ArticleId><ArticleId IdType="pmc">PMC2738086</ArticleId><ArticleId IdType="pubmed">19625480</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsop J., Flewett T.H., Foster J.R. "Hand-foot-and-mouth disease" in Birmingham in 1959. Br. Med. J. 1960;2:1708–1711. doi: 10.1136/bmj.2.5214.1708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.2.5214.1708</ArticleId><ArticleId IdType="pmc">PMC2098292</ArticleId><ArticleId IdType="pubmed">13682692</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson C.R., Doane F.W., Rhodes A.J. Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus. Can. Med. Assoc. J. 1958;79:615–621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1830188</ArticleId><ArticleId IdType="pubmed">13585281</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseha S.T. Polio: The Disease that Reemerged after Six Years in Ethiopia. Ethiop. J. Health Sci. 2021;31:897–902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8512932</ArticleId><ArticleId IdType="pubmed">34703190</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L.G., Parashar U.D., Lye M.S., Ong F.G., Zaki S.R., Alexander J.P., Ho K.K., Han L.L., Pallansch M.A., Suleiman A.B., et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: Clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin. Infect. Dis. 2000;31:678–683. doi: 10.1086/314032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.R., Tuan Y.C., Tsai H.P., Yan J.J., Liu C.C., Su I.J. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J. Clin. Microbiol. 2002;40:10–15. doi: 10.1128/jcm.40.1.10-15.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.40.1.10-15.2002</ArticleId><ArticleId IdType="pmc">PMC120096</ArticleId><ArticleId IdType="pubmed">11773085</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., Shih S.R. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 1999;341:929–935. doi: 10.1056/nejm199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer T.K., Nielsen A.Y., Sydenham T.V., Andersen P.H., Andersen B., Midgley S.E. Emergence of enterovirus 71 C4a in Denmark, 2009 to 2013. EuroSurveillance. 2014;19:20911. doi: 10.2807/1560-7917.es2014.19.38.20911.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.es2014.19.38.20911</ArticleId><ArticleId IdType="pubmed">25306878</ArticleId></ArticleIdList></Reference><Reference><Citation>Luciani L., Morand A., Zandotti C., Piorkowski G., Boutin A., Mazenq J., Minodier P., Ninove L., Nougairède A. Circulation of enterovirus A71 during 2019-2020, Marseille, France. J. Med. Virol. 2021;93:5163–5166. doi: 10.1002/jmv.26893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26893</ArticleId><ArticleId IdType="pubmed">33605462</ArticleId></ArticleIdList></Reference><Reference><Citation>Karrasch M., Fischer E., Scholten M., Sauerbrei A., Henke A., Renz D.M., Mentzel H.J., Böer K., Böttcher S., Diedrich S., et al. A severe pediatric infection with a novel enterovirus A71 strain, Thuringia, Germany. J. Clin. Virol. 2016;84:90–95. doi: 10.1016/j.jcv.2016.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2016.09.007</ArticleId><ArticleId IdType="pubmed">27771495</ArticleId></ArticleIdList></Reference><Reference><Citation>González-Sanz R., Casas-Alba D., Launes C., Muñoz-Almagro C., Ruiz-García M.M., Alonso M., González-Abad M.J., Megías G., Rabella N., Del Cuerpo M., et al. Molecular epidemiology of an enterovirus A71 outbreak associated with severe neurological disease, Spain, 2016. EuroSurveillance. 2019;24:1800089. doi: 10.2807/1560-7917.Es.2019.24.7.1800089.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.Es.2019.24.7.1800089</ArticleId><ArticleId IdType="pmc">PMC6381658</ArticleId><ArticleId IdType="pubmed">30782267</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieczorek M., Purzyńska M., Krzysztoszek A., Ciąćka A., Figas A., Szenborn L. Genetic characterization of enterovirus A71 isolates from severe neurological cases in Poland. J. Med. Virol. 2018;90:372–376. doi: 10.1002/jmv.24958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24958</ArticleId><ArticleId IdType="pubmed">28960454</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q., Ding J., Cao J., Huang Q., Hong C., Yang B. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: Outbreaks of coxsackieviruses A10. J. Med. Virol. 2015;87:954–960. doi: 10.1002/jmv.24151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24151</ArticleId><ArticleId IdType="pubmed">25754274</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain K.M., Leong K.L., Ng M.M., Chu J.J. The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71. J. Biol. Chem. 2011;286:309–321. doi: 10.1074/jbc.M110.168468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.168468</ArticleId><ArticleId IdType="pmc">PMC3012988</ArticleId><ArticleId IdType="pubmed">20956521</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H.Y., Yang Y.T., Yu S.L., Hsiao K.N., Liu C.C., Sia C., Chow Y.H. Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection. J. Virol. 2013;87:9064–9076. doi: 10.1128/jvi.00573-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00573-13</ArticleId><ArticleId IdType="pmc">PMC3754029</ArticleId><ArticleId IdType="pubmed">23760234</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao X.Y., Guo L., Huang D.Y., Chang X.L., Qiu Q.C. Distribution of EV71 receptors SCARB2 and PSGL-1 in human tissues. Virus Res. 2014;190:40–52. doi: 10.1016/j.virusres.2014.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.05.007</ArticleId><ArticleId IdType="pubmed">24997419</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M., Wang X., Wang Q., Wang Y., Lin J., Sun Y., Li X., Zhang L., Lou Z., Wang J., et al. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell. 2014;5:692–703. doi: 10.1007/s13238-014-0087-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0087-3</ArticleId><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Shingler K.L., Yoder J.L., Carnegie M.S., Ashley R.E., Makhov A.M., Conway J.F., Hafenstein S. The enterovirus 71 A-particle forms a gateway to allow genome release: A cryoEM study of picornavirus uncoating. PLoS Pathog. 2013;9:e1003240. doi: 10.1371/journal.ppat.1003240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003240</ArticleId><ArticleId IdType="pmc">PMC3605244</ArticleId><ArticleId IdType="pubmed">23555253</ArticleId></ArticleIdList></Reference><Reference><Citation>Staring J., von Castelmur E., Blomen V.A., van den Hengel L.G., Brockmann M., Baggen J., Thibaut H.J., Nieuwenhuis J., Janssen H., van Kuppeveld F.J., et al. PLA2G16 represents a switch between entry and clearance of Picornaviridae. Nature. 2017;541:412–416. doi: 10.1038/nature21032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21032</ArticleId><ArticleId IdType="pubmed">28077878</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson S.M., Tsueng G., Sin J., Mangale V., Rahawi S., McIntyre L.L., Williams W., Kha N., Cruz C., Hancock B.M., et al. Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers. PLoS Pathog. 2014;10:e1004045. doi: 10.1371/journal.ppat.1004045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004045</ArticleId><ArticleId IdType="pmc">PMC3983045</ArticleId><ArticleId IdType="pubmed">24722773</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.H., Du W., Hagemeijer M.C., Takvorian P.M., Pau C., Cali A., Brantner C.A., Stempinski E.S., Connelly P.S., Ma H.C., et al. Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell. 2015;160:619–630. doi: 10.1016/j.cell.2015.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.032</ArticleId><ArticleId IdType="pmc">PMC6704014</ArticleId><ArticleId IdType="pubmed">25679758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.K., Sam I.C., Chan Y.F. The Autophagic Machinery in Enterovirus Infection. Viruses. 2016;8:32. doi: 10.3390/v8020032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8020032</ArticleId><ArticleId IdType="pmc">PMC4776187</ArticleId><ArticleId IdType="pubmed">26828514</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., Li C., Liu X., Chiu M.C., Wang D., Wei Y., Chu H., Cai J.P., Hau-Yee Chan I., Kak-Yuen Wong K., et al. Human Intestinal Organoids Recapitulate Enteric Infections of Enterovirus and Coronavirus. Stem Cell Rep. 2021;16:493–504. doi: 10.1016/j.stemcr.2021.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.02.009</ArticleId><ArticleId IdType="pmc">PMC7940440</ArticleId><ArticleId IdType="pubmed">33626333</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Rui J., Niu Y., Xie F., Wang Y., Li Z., Liu C., Yu S., Huang J., Luo L., et al. Analysis of HFMD Transmissibility Among the Whole Population and Age Groups in a Large City of China. Front. Public Health. 2022;10:850369. doi: 10.3389/fpubh.2022.850369.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.850369</ArticleId><ArticleId IdType="pmc">PMC9035867</ArticleId><ArticleId IdType="pubmed">35480581</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W., Liao Q., Viboud C., Zhang J., Sun J., Wu J.T., Chang Z., Liu F., Fang V.J., Zheng Y., et al. Hand, foot, and mouth disease in China, 2008–2012: An epidemiological study. Lancet Infect. Dis. 2014;14:308–318. doi: 10.1016/s1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Elrick M.J., Pekosz A., Duggal P. Enterovirus D68 molecular and cellular biology and pathogenesis. J. Biol. Chem. 2021;296:100317. doi: 10.1016/j.jbc.2021.100317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100317</ArticleId><ArticleId IdType="pmc">PMC7949111</ArticleId><ArticleId IdType="pubmed">33484714</ArticleId></ArticleIdList></Reference><Reference><Citation>Majer O., Liu B., Barton G.M. Nucleic acid-sensing TLRs: Trafficking and regulation. Curr. Opin. Immunol. 2017;44:26–33. doi: 10.1016/j.coi.2016.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2016.10.003</ArticleId><ArticleId IdType="pmc">PMC5446938</ArticleId><ArticleId IdType="pubmed">27907816</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehwinkel J., Gack M.U. RIG-I-like receptors: Their regulation and roles in RNA sensing. Nat. Rev. Immunol. 2020;20:537–551. doi: 10.1038/s41577-020-0288-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0288-3</ArticleId><ArticleId IdType="pmc">PMC7094958</ArticleId><ArticleId IdType="pubmed">32203325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lockhart A., Mucida D., Parsa R. Immunity to enteric viruses. Immunity. 2022;55:800–818. doi: 10.1016/j.immuni.2022.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.04.007</ArticleId><ArticleId IdType="pmc">PMC9257994</ArticleId><ArticleId IdType="pubmed">35545029</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng H., Lenarcic E.M., Yamane D., Wauthier E., Mo J., Guo H., McGivern D.R., González-López O., Misumi I., Reid L.M., et al. NLRX1 promotes immediate IRF1-directed antiviral responses by limiting dsRNA-activated translational inhibition mediated by PKR. Nat. Immunol. 2017;18:1299–1309. doi: 10.1038/ni.3853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3853</ArticleId><ArticleId IdType="pmc">PMC5690873</ArticleId><ArticleId IdType="pubmed">28967880</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng H., Zhang Y.B., Gui J.F., Lemon S.M., Yamane D. Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses. PLoS Pathog. 2021;17:e1009220. doi: 10.1371/journal.ppat.1009220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009220</ArticleId><ArticleId IdType="pmc">PMC7819612</ArticleId><ArticleId IdType="pubmed">33476326</ArticleId></ArticleIdList></Reference><Reference><Citation>Su R., Shereen M.A., Zeng X., Liang Y., Li W., Ruan Z., Li Y., Liu W., Liu Y., Wu K., et al. The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine. mBio. 2020;11:e02540-20. doi: 10.1128/mBio.02540-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02540-20</ArticleId><ArticleId IdType="pmc">PMC7683398</ArticleId><ArticleId IdType="pubmed">33203755</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.L., Lu M.Y., Chuang C.F., Kuo Y., Lin H.E., Li F.A., Wang J.R., Hsueh Y.P., Liao F. TLR7 Is Critical for Anti-Viral Humoral Immunity to EV71 Infection in the Spinal Cord. Front. Immunol. 2020;11:614743. doi: 10.3389/fimmu.2020.614743.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.614743</ArticleId><ArticleId IdType="pmc">PMC7935532</ArticleId><ArticleId IdType="pubmed">33679702</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao H.B., Chou A.H., Lin S.I., Chen I.H., Lien S.P., Liu C.C., Chong P., Liu S.J. Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns. J. Virol. 2014;88:11658–11670. doi: 10.1128/jvi.00867-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00867-14</ArticleId><ArticleId IdType="pmc">PMC4178751</ArticleId><ArticleId IdType="pubmed">25078697</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R.L., Kao L.T., Lin S.J., Wang R.Y., Shih S.R. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS ONE. 2013;8:e63431. doi: 10.1371/journal.pone.0063431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063431</ArticleId><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., Hato S.V., Langereis M.A., Zoll J., Virgen-Slane R., Peisley A., Hur S., Semler B.L., van Rij R.P., van Kuppeveld F.J. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep. 2012;2:1187–1196. doi: 10.1016/j.celrep.2012.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.10.005</ArticleId><ArticleId IdType="pmc">PMC7103987</ArticleId><ArticleId IdType="pubmed">23142662</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung V., Ellegast J., Kim S., Brzózka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., et al. 5’-Triphosphate RNA is the ligand for RIG-I. Science. 2006;314:994–997. doi: 10.1126/science.1132505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1132505</ArticleId><ArticleId IdType="pubmed">17038590</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441:101–105. doi: 10.1038/nature04734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04734</ArticleId><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., Hiiragi A., Dermody T.S., Fujita T., Akira S. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 2008;205:1601–1610. doi: 10.1084/jem.20080091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20080091</ArticleId><ArticleId IdType="pmc">PMC2442638</ArticleId><ArticleId IdType="pubmed">18591409</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W., Zhou Z., Rui Y., Ye R., Xia F., Guo F., Liu X., Su J., Lou M., Yu X.F. TRAF3 activates STING-mediated suppression of EV-A71 and target of viral evasion. Signal Transduct. Target. Ther. 2023;8:79. doi: 10.1038/s41392-022-01287-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01287-2</ArticleId><ArticleId IdType="pmc">PMC9950063</ArticleId><ArticleId IdType="pubmed">36823147</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou W.C., Jha S., Linhoff M.W., Ting J.P. The NLR gene family: From discovery to present day. Nat. Rev. Immunol. 2023;23:635–654. doi: 10.1038/s41577-023-00849-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00849-x</ArticleId><ArticleId IdType="pmc">PMC11171412</ArticleId><ArticleId IdType="pubmed">36973360</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S., Ding S., Wang P., Wei Z., Pan W., Palm N.W., Yang Y., Yu H., Li H.B., Wang G., et al. Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells. Nature. 2017;546:667–670. doi: 10.1038/nature22967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22967</ArticleId><ArticleId IdType="pmc">PMC5787375</ArticleId><ArticleId IdType="pubmed">28636595</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Yang R., Yang F., Han Y., Ren Y., Xiong X., Wang X., Bi Y., Li L., Qiu Y., et al. Echovirus 11 infection induces pyroptotic cell death by facilitating NLRP3 inflammasome activation. PLoS Pathog. 2022;18:e1010787. doi: 10.1371/journal.ppat.1010787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010787</ArticleId><ArticleId IdType="pmc">PMC9455886</ArticleId><ArticleId IdType="pubmed">36026486</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Z., Gao X., Yang Q., Lun J., Xiao H., Zhong J., Cao H. Phosphorylation of ERK-Dependent NF-κB Triggers NLRP3 Inflammasome Mediated by Vimentin in EV71-Infected Glioblastoma Cells. Molecules. 2022;27:4190. doi: 10.3390/molecules27134190.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27134190</ArticleId><ArticleId IdType="pmc">PMC9268588</ArticleId><ArticleId IdType="pubmed">35807435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Lei X., Xiao X., Yang C., Lu W., Huang Z., Leng Q., Jin Q., He B., Meng G., et al. Reciprocal Regulation between Enterovirus 71 and the NLRP3 Inflammasome. Cell Rep. 2015;12:42–48. doi: 10.1016/j.celrep.2015.05.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.05.047</ArticleId><ArticleId IdType="pubmed">26119741</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauernfried S., Scherr M.J., Pichlmair A., Duderstadt K.E., Hornung V. Human NLRP1 is a sensor for double-stranded RNA. Science. 2021;371:eabd0811. doi: 10.1126/science.abd0811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd0811</ArticleId><ArticleId IdType="pubmed">33243852</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H., König R., Deng M., Riess M., Mo J., Zhang L., Petrucelli A., Yoh S.M., Barefoot B., Samo M., et al. NLRX1 Sequesters STING to Negatively Regulate the Interferon Response, Thereby Facilitating the Replication of HIV-1 and DNA Viruses. Cell Host Microbe. 2016;19:515–528. doi: 10.1016/j.chom.2016.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.03.001</ArticleId><ArticleId IdType="pmc">PMC4833116</ArticleId><ArticleId IdType="pubmed">27078069</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro L.K., Daugherty M.D. Tripping the wire: Sensing of viral protease activity by CARD8 and NLRP1 inflammasomes. Curr. Opin. Immunol. 2023;83:102354. doi: 10.1016/j.coi.2023.102354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2023.102354</ArticleId><ArticleId IdType="pmc">PMC10528193</ArticleId><ArticleId IdType="pubmed">37311351</ArticleId></ArticleIdList></Reference><Reference><Citation>Orzalli M.H., Parameswaran P. Effector-triggered immunity in mammalian antiviral defense. Trends Immunol. 2022;43:1006–1017. doi: 10.1016/j.it.2022.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.10.004</ArticleId><ArticleId IdType="pubmed">36369102</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Gao H., Clark K.M., Mugisha C.S., Davis K., Tang J.P., Harlan G.H., DeSelm C.J., Presti R.M., Kutluay S.B., et al. CARD8 is an inflammasome sensor for HIV-1 protease activity. Science. 2021;371:abe1707. doi: 10.1126/science.abe1707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe1707</ArticleId><ArticleId IdType="pmc">PMC8029496</ArticleId><ArticleId IdType="pubmed">33542150</ArticleId></ArticleIdList></Reference><Reference><Citation>Planès R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K., Paillette P., Valadão A.C., Robinson K.S., Bastard P., et al. Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells. Mol. Cell. 2022;82:2385–2400.e2389. doi: 10.1016/j.molcel.2022.04.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.04.033</ArticleId><ArticleId IdType="pmc">PMC9108100</ArticleId><ArticleId IdType="pubmed">35594856</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson K.S., Teo D.E.T., Tan K.S., Toh G.A., Ong H.H., Lim C.K., Lay K., Au B.V., Lew T.S., Chu J.J.H., et al. Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia. Science. 2020;370:aay2002. doi: 10.1126/science.aay2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aay2002</ArticleId><ArticleId IdType="pubmed">33093214</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X., Li X., Zhou Y., Mei M., Liu P., Zhao J., Peng W., Jiang Z.B., Yang S., Iverson B.L., et al. Quantitative Analysis of the Substrate Specificity of Human Rhinovirus 3C Protease and Exploration of Its Substrate Recognition Mechanisms. ACS Chem. Biol. 2020;15:63–73. doi: 10.1021/acschembio.9b00539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.9b00539</ArticleId><ArticleId IdType="pubmed">31613083</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsu B.V., Beierschmitt C., Ryan A.P., Agarwal R., Mitchell P.S., Daugherty M.D. Diverse viral proteases activate the NLRP1 inflammasome. eLife. 2021;10:60609. doi: 10.7554/eLife.60609.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.60609</ArticleId><ArticleId IdType="pmc">PMC7857732</ArticleId><ArticleId IdType="pubmed">33410748</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng H., Sander A.L., Moreira-Soto A., Yamane D., Drexler J.F., Lemon S.M. Hepatovirus 3ABC proteases and evolution of mitochondrial antiviral signaling protein (MAVS) J. Hepatol. 2019;71:25–34. doi: 10.1016/j.jhep.2019.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2019.02.020</ArticleId><ArticleId IdType="pmc">PMC6581616</ArticleId><ArticleId IdType="pubmed">30876947</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadkarni R., Chu W.C., Lee C.Q.E., Mohamud Y., Yap L., Toh G.A., Beh S., Lim R., Fan Y.M., Zhang Y.L., et al. Viral proteases activate the CARD8 inflammasome in the human cardiovascular system. J. Exp. Med. 2022;219:e20212117. doi: 10.1084/jem.20212117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20212117</ArticleId><ArticleId IdType="pmc">PMC9499823</ArticleId><ArticleId IdType="pubmed">36129453</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsu B.V., Agarwal R., Gokhale N.S., Kulsuptrakul J., Ryan A.P., Fay E.J., Castro L.K., Beierschmitt C., Yap C., Turcotte E.A., et al. Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome. PLoS Biol. 2023;21:e3002144. doi: 10.1371/journal.pbio.3002144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3002144</ArticleId><ArticleId IdType="pmc">PMC10249858</ArticleId><ArticleId IdType="pubmed">37289745</ArticleId></ArticleIdList></Reference><Reference><Citation>Odendall C., Dixit E., Stavru F., Bierne H., Franz K.M., Durbin A.F., Boulant S., Gehrke L., Cossart P., Kagan J.C. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat. Immunol. 2014;15:717–726. doi: 10.1038/ni.2915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2915</ArticleId><ArticleId IdType="pmc">PMC4106986</ArticleId><ArticleId IdType="pubmed">24952503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear H.M., Schoggins J.W., Diamond M.S. Shared and Distinct Functions of Type I and Type III Interferons. Immunity. 2019;50:907–923. doi: 10.1016/j.immuni.2019.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.03.025</ArticleId><ArticleId IdType="pmc">PMC6839410</ArticleId><ArticleId IdType="pubmed">30995506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingle H., Peterson S.T., Baldridge M.T. Distinct Effects of Type I and III Interferons on Enteric Viruses. Viruses. 2018;10:46. doi: 10.3390/v10010046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10010046</ArticleId><ArticleId IdType="pmc">PMC5795459</ArticleId><ArticleId IdType="pubmed">29361691</ArticleId></ArticleIdList></Reference><Reference><Citation>Good C., Wells A.I., Coyne C.B. Type III interferon signaling restricts enterovirus 71 infection of goblet cells. Sci. Adv. 2019;5:eaau4255. doi: 10.1126/sciadv.aau4255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau4255</ArticleId><ArticleId IdType="pmc">PMC6402847</ArticleId><ArticleId IdType="pubmed">30854425</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman M.C., Wells A.I., Ciomperlik-Patton J., Myerburg M.M., Yang L., Konopka-Anstadt J., Coyne C.B. Respiratory and intestinal epithelial cells exhibit differential susceptibility and innate immune responses to contemporary EV-D68 isolates. eLife. 2021;10:66687. doi: 10.7554/eLife.66687.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.66687</ArticleId><ArticleId IdType="pmc">PMC8285104</ArticleId><ArticleId IdType="pubmed">34196272</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti M., Khanbabaei H., Teimoori A. An update on enterovirus 71 infection and interferon type I response. Rev. Med. Virol. 2019;29:e2016. doi: 10.1002/rmv.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2016</ArticleId><ArticleId IdType="pmc">PMC7169063</ArticleId><ArticleId IdType="pubmed">30378208</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.H., Du J., Yu J., Zhao Y., Wang Y., Hua S., Zhao K. Coxsackievirus A6 2C protein antagonizes IFN-β production through MDA5 and RIG-I depletion. J. Virol. 2023;97:e0107523. doi: 10.1128/jvi.01075-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01075-23</ArticleId><ArticleId IdType="pmc">PMC10688345</ArticleId><ArticleId IdType="pubmed">37847581</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., Langereis M.A., Lork M., Nguyen M., Hato S.V., Lanke K., Emdad L., Bhoopathi P., Fisher P.B., Lloyd R.E., et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J. Virol. 2014;88:3369–3378. doi: 10.1128/jvi.02712-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., He B., Wang J. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 2010;84:8051–8061. doi: 10.1128/jvi.02491-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02491-09</ArticleId><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Li X., Li P., Pan Z., Ding Y., Zou D., Zheng L., Zhang Y., Li L., Xiao L., et al. Enterovirus 71 inhibits cellular type I interferon signaling by inhibiting host RIG-I ubiquitination. Microb. Pathog. 2016;100:84–89. doi: 10.1016/j.micpath.2016.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2016.09.001</ArticleId><ArticleId IdType="pubmed">27633794</ArticleId></ArticleIdList></Reference><Reference><Citation>Bignell G.R., Warren W., Seal S., Takahashi M., Rapley E., Barfoot R., Green H., Brown C., Biggs P.J., Lakhani S.R., et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat. Genet. 2000;25:160–165. doi: 10.1038/76006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/76006</ArticleId><ArticleId IdType="pubmed">10835629</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C., He X., Zheng Z., Zhang Z., Wei C., Guan K., Hou L., Zhang B., Zhu L., Cao Y., et al. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response. J. Virol. 2014;88:11356–11368. doi: 10.1128/jvi.01400-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01400-14</ArticleId><ArticleId IdType="pmc">PMC4178780</ArticleId><ArticleId IdType="pubmed">25056901</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Cheng M., Liu B., Yuan M., Chen D., Wang Y., Wu Z. DEAD-Box Helicase DDX6 Facilitated RIG-I-Mediated Type-I Interferon Response to EV71 Infection. Front. Cell. Infect. Microbiol. 2021;11:725392. doi: 10.3389/fcimb.2021.725392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.725392</ArticleId><ArticleId IdType="pmc">PMC8414799</ArticleId><ArticleId IdType="pubmed">34485180</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R.L., Chen C.J., Wang R.Y.L., Huang H.I., Lin Y.H., Tam E.H., Tu W.J., Wu S.E., Shih S.R. Role of Enteroviral RNA-Dependent RNA Polymerase in Regulation of MDA5-Mediated Beta Interferon Activation. J. Virol. 2019;93:e00132-19. doi: 10.1128/jvi.00132-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00132-19</ArticleId><ArticleId IdType="pmc">PMC6498057</ArticleId><ArticleId IdType="pubmed">30814289</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Hu Y., Li J., Zheng H., Wang J., Guo L., Shi H., Liu L. Suppression of the toll-like receptor 7-dependent type I interferon production pathway by autophagy resulting from enterovirus 71 and coxsackievirus A16 infections facilitates their replication. Arch. Virol. 2018;163:135–144. doi: 10.1007/s00705-017-3592-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-017-3592-x</ArticleId><ArticleId IdType="pmc">PMC5756282</ArticleId><ArticleId IdType="pubmed">29052054</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Zheng Y., Mo J., Wang W., Luo Z., Li Y., Chen X., Zhang Q., Wu K., Liu W., et al. Sox4 represses host innate immunity to facilitate pathogen infection by hijacking the TLR signaling networks. Virulence. 2021;12:704–722. doi: 10.1080/21505594.2021.1882775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2021.1882775</ArticleId><ArticleId IdType="pmc">PMC7894441</ArticleId><ArticleId IdType="pubmed">33517839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Xiao F., Wan P., Pan P., Zhang Y., Liu F., Wu K., Liu Y., Wu J. EV71 3D Protein Binds with NLRP3 and Enhances the Assembly of Inflammasome Complex. PLoS Pathog. 2017;13:e1006123. doi: 10.1371/journal.ppat.1006123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006123</ArticleId><ArticleId IdType="pmc">PMC5245909</ArticleId><ArticleId IdType="pubmed">28060938</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H.I., Lin J.Y., Chen S.H. EV71 Infection Induces IFNβ Expression in Neural Cells. Viruses. 2019;11:1121. doi: 10.3390/v11121121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11121121</ArticleId><ArticleId IdType="pmc">PMC6950376</ArticleId><ArticleId IdType="pubmed">31817126</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Xi X., Lei X., Zhang X., Cui S., Wang J., Jin Q., Zhao Z. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog. 2013;9:e1003231. doi: 10.1371/journal.ppat.1003231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Sun Z., Liu X., Jin Q., He B., Wang J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 2011;85:8811–8818. doi: 10.1128/jvi.00447-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00447-11</ArticleId><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhang S., Song W., Zhang W., Li J., Li C., Qiu Y., Fang Y., Jiang Q., Li X., et al. Exosomes from EV71-infected oral epithelial cells can transfer miR-30a to promote EV71 infection. Oral Dis. 2020;26:778–788. doi: 10.1111/odi.13283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.13283</ArticleId><ArticleId IdType="pubmed">31958204</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng N., Zhou Z., Li Y., Zhao L., Xue Z., Lu R., Jia K. Enterovirus 71-induced has-miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. Virus Res. 2017;237:27–36. doi: 10.1016/j.virusres.2017.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2017.05.008</ArticleId><ArticleId IdType="pubmed">28506791</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnabei L., Laplantine E., Mbongo W., Rieux-Laucat F., Weil R. NF-κB: At the Borders of Autoimmunity and Inflammation. Front. Immunol. 2021;12:716469. doi: 10.3389/fimmu.2021.716469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.716469</ArticleId><ArticleId IdType="pmc">PMC8381650</ArticleId><ArticleId IdType="pubmed">34434197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoesel B., Schmid J.A. The complexity of NF-κB signaling in inflammation and cancer. Mol. Cancer. 2013;12:86. doi: 10.1186/1476-4598-12-86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-4598-12-86</ArticleId><ArticleId IdType="pmc">PMC3750319</ArticleId><ArticleId IdType="pubmed">23915189</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Zheng Z., Liu Y., Zhang Z., Liu Q., Meng J., Ke X., Hu Q., Wang H. 2C Proteins of Enteroviruses Suppress IKKβ Phosphorylation by Recruiting Protein Phosphatase 1. J. Virol. 2016;90:5141–5151. doi: 10.1128/jvi.03021-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.03021-15</ArticleId><ArticleId IdType="pmc">PMC4859720</ArticleId><ArticleId IdType="pubmed">26962213</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji L., Yang E., He S., Jin Y., Chen D. Enterovirus 2C Protein Suppresses IKKα Phosphorylation by Recruiting IKKβ and IKKα into Viral Inclusion Bodies. Viral Immunol. 2021;34:218–226. doi: 10.1089/vim.2020.0173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2020.0173</ArticleId><ArticleId IdType="pubmed">33226912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Han N., Xiao X., Jin Q., He B., Wang J. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex. J. Virol. 2014;88:9830–9841. doi: 10.1128/jvi.01425-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01425-14</ArticleId><ArticleId IdType="pmc">PMC4136319</ArticleId><ArticleId IdType="pubmed">24942571</ArticleId></ArticleIdList></Reference><Reference><Citation>Du H., Yin P., Yang X., Zhang L., Jin Q., Zhu G. Enterovirus 71 2C Protein Inhibits NF-κB Activation by Binding to RelA(p65) Sci. Rep. 2015;5:14302. doi: 10.1038/srep14302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep14302</ArticleId><ArticleId IdType="pmc">PMC4585786</ArticleId><ArticleId IdType="pubmed">26394554</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang L., Gu J., Yang X., Yuan Y., Guo H., Zhou W., Ma J., Chen Y., Wu Y., Zheng H., et al. Ubiquitin-specific protease 24 promotes EV71 infection by restricting K63-linked polyubiquitination of TBK1. Virol. Sin. 2023;38:75–83. doi: 10.1016/j.virs.2022.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virs.2022.11.001</ArticleId><ArticleId IdType="pmc">PMC10006192</ArticleId><ArticleId IdType="pubmed">36334706</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Xiao X., Xue Q., Jin Q., He B., Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J. Virol. 2013;87:1690–1698. doi: 10.1128/jvi.01855-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01855-12</ArticleId><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho B.C., Yu I.S., Lu L.F., Rudensky A., Chen H.Y., Tsai C.W., Chang Y.L., Wu C.T., Chang L.Y., Shih S.R., et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat. Commun. 2014;5:3344. doi: 10.1038/ncomms4344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4344</ArticleId><ArticleId IdType="pubmed">24561744</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Yi L., Zhao J., Yu J., Chen Y., Lin M.C., Kung H.F., He M.L. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 2012;86:3767–3776. doi: 10.1128/jvi.06687-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.06687-11</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhang Z., Zhao X., Yu R., Zhang X., Wu S., Liu J., Chi X., Song X., Fu L., et al. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Viral Immunol. 2014;27:267–276. doi: 10.1089/vim.2013.0127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2013.0127</ArticleId><ArticleId IdType="pubmed">24905060</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Wang X., Wang Y., Li Y., Chen Y., Wong Y.T., He J., He M.L. Secreted LRPAP1 binds and triggers IFNAR1 degradation to facilitate virus evasion from cellular innate immunity. Signal Transduct. Target. Ther. 2023;8:374. doi: 10.1038/s41392-023-01630-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01630-1</ArticleId><ArticleId IdType="pmc">PMC10518340</ArticleId><ArticleId IdType="pubmed">37743411</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.C., Chen S.O., Chang S.P., Lee Y.P., Yu C.K., Chen C.L., Tseng P.C., Hsieh C.Y., Chen S.H., Lin C.F. Enterovirus 71 Proteins 2A and 3D Antagonize the Antiviral Activity of Gamma Interferon via Signaling Attenuation. J. Virol. 2015;89:7028–7037. doi: 10.1128/jvi.00205-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00205-15</ArticleId><ArticleId IdType="pmc">PMC4473548</ArticleId><ArticleId IdType="pubmed">25926657</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung H.C., Wang H.C., Shih S.R., Teng I.F., Tseng C.P., Hsu J.T. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J. Infect. Dis. 2011;203:1784–1790. doi: 10.1093/infdis/jir174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir174</ArticleId><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L., Lu B., Zheng Z., Miao Y., Liu Y., Zhang Y., Zheng C., Ke X., Hu Q., Wang H. The 3C protease of enterovirus A71 counteracts the activity of host zinc-finger antiviral protein (ZAP) J. Gen. Virol. 2018;99:73–85. doi: 10.1099/jgv.0.000982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000982</ArticleId><ArticleId IdType="pubmed">29182509</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Tian L., Wang J., Zheng B., Zhang W. EV71 3C protease cleaves host anti-viral factor OAS3 and enhances virus replication. Virol. Sin. 2022;37:418–426. doi: 10.1016/j.virs.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virs.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9243667</ArticleId><ArticleId IdType="pubmed">35504537</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Sun M., Yuan X., Ji L., Jin Y., Cardona C.J., Xing Z. Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin-α1 degradation. J. Biol. Chem. 2017;292:10262–10274. doi: 10.1074/jbc.M116.745729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.745729</ArticleId><ArticleId IdType="pmc">PMC5473229</ArticleId><ArticleId IdType="pubmed">28455446</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W., Hou M., Liu X., Li Z., Yang Y., Zhang W. Induction of SOCS Expression by EV71 Infection Promotes EV71 Replication. BioMed Res. Int. 2020;2020:2430640. doi: 10.1155/2020/2430640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/2430640</ArticleId><ArticleId IdType="pmc">PMC7054758</ArticleId><ArticleId IdType="pubmed">32149091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang P.Y., Chong C.W.H., Alonso S. Viral determinants that drive Enterovirus-A71 fitness and virulence. Emerg. Microbes Infect. 2021;10:713–724. doi: 10.1080/22221751.2021.1906754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1906754</ArticleId><ArticleId IdType="pmc">PMC8043536</ArticleId><ArticleId IdType="pubmed">33745413</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Hu Y., Zheng M. Enterovirus A71 antivirals: Past, present, and future. Acta Pharm. Sin. B. 2022;12:1542–1566. doi: 10.1016/j.apsb.2021.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2021.08.017</ArticleId><ArticleId IdType="pmc">PMC9279511</ArticleId><ArticleId IdType="pubmed">35847514</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>